Trupanion, Inc. (NASDAQ:TRUP) Shares Sold by O Brien Greene & Co. Inc

O Brien Greene & Co. Inc lowered its position in shares of Trupanion, Inc. (NASDAQ:TRUP) by 41.3% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 12,677 shares of the financial services provider’s stock after selling 8,923 shares during the quarter. O Brien Greene & Co. Inc’s holdings in Trupanion were worth $966,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the business. Bank Julius Baer & Co. Ltd Zurich raised its stake in shares of Trupanion by 823.8% in the first quarter. Bank Julius Baer & Co. Ltd Zurich now owns 388 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 346 shares during the last quarter. McIlrath & Eck LLC purchased a new position in Trupanion during the 1st quarter worth approximately $33,000. Archer Investment Corp acquired a new stake in Trupanion during the 4th quarter valued at approximately $39,000. Meeder Asset Management Inc. boosted its holdings in shares of Trupanion by 7,057.1% in the 1st quarter. Meeder Asset Management Inc. now owns 501 shares of the financial services provider’s stock valued at $39,000 after acquiring an additional 494 shares during the last quarter. Finally, Berman Capital Advisors LLC acquired a new stake in shares of Trupanion in the fourth quarter worth $43,000. Institutional investors and hedge funds own 78.90% of the company’s stock.

In other news, CEO Darryl Rawlings sold 4,000 shares of Trupanion stock in a transaction on Tuesday, April 6th. The stock was sold at an average price of $75.65, for a total value of $302,600.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Tricia Plouf sold 1,500 shares of the business’s stock in a transaction on Thursday, March 18th. The shares were sold at an average price of $87.41, for a total value of $131,115.00. Following the completion of the sale, the chief financial officer now owns 29,467 shares in the company, valued at approximately $2,575,710.47. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 25,909 shares of company stock valued at $2,124,538. 6.77% of the stock is currently owned by insiders.

Several equities research analysts have weighed in on the company. TheStreet downgraded Trupanion from a “c-” rating to a “d+” rating in a research report on Thursday, May 13th. Lake Street Capital boosted their price target on Trupanion from $85.00 to $150.00 and gave the company a “buy” rating in a report on Thursday, February 11th. Evercore ISI initiated coverage on Trupanion in a research report on Monday, April 5th. They set an “outperform” rating and a $100.00 price target on the stock. Canaccord Genuity boosted their price objective on Trupanion from $140.00 to $150.00 and gave the company a “buy” rating in a research report on Thursday, February 11th. Finally, Zacks Investment Research lowered Trupanion from a “hold” rating to a “strong sell” rating in a research report on Saturday, May 1st. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $86.57.

Shares of Trupanion stock traded down $0.34 on Friday, hitting $93.58. 3,549 shares of the company were exchanged, compared to its average volume of 395,765. Trupanion, Inc. has a 1-year low of $30.78 and a 1-year high of $126.53. The stock has a market cap of $3.75 billion, a PE ratio of -218.81 and a beta of 1.92. The stock’s 50-day moving average is $81.51.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Thursday, April 29th. The financial services provider reported ($0.31) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.08) by ($0.23). Trupanion had a negative net margin of 3.15% and a negative return on equity of 7.13%. The firm had revenue of $154.69 million for the quarter, compared to analysts’ expectations of $151.79 million. As a group, research analysts anticipate that Trupanion, Inc. will post -0.75 EPS for the current year.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc changed its name to Trupanion, Inc in 2013.

Recommended Story: Stop Order Uses For Individual Investors

Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP).

Institutional Ownership by Quarter for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.